VNRX

Conviction 27HealthcareScan · Mon, Aug 10, 2026

VNRX$0.7535-2.81%

ResistanceSupportVol 14

Vol MA14 1.04M

May 11May 28Jun 16Jul 6Jul 23Aug 10

VOLITIONRX LTDIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESwww.volition.com ↗

Price0.7535

Change-2.81%

Gap+1.35%

Rel volume0.20×

Avg volume780.58K

Avg $ vol649.35K

SMA 200.9383

SMA 501.30

SMA 2000.7684

Price vs 50-41.91%

Price vs 200-1.93%

MA stackmixed

50/200 cross—

Supertrenddown · 1.07

RSI (14)30

MACD hist0.01

MACD crossbull · 1d

Stoch %K / %D13 / 15

ADX (14)30

+DI / −DI14 / 27

RSI divergence—

MACD divergenceBullish

ATR %+14.65%

ADR %10.69%

52w high3.13

52w low0.1362

From 52w high-75.93%

Above 52w low+453.23%

New 52w highNo

SqueezeOff

Bollinger width74.07%

%B0.23

Donchian pos10.23%

Donchian high1.31

Donchian low0.6901

AVWAP (52w high)1.23

vs AVWAP high-38.60%

AVWAP (52w low)1.35

vs AVWAP low-44.37%

OBV trendUp

Chaikin MF (20)-0.31

Today vs 20d0.20×

Avg vol (14d)1.04M

Avg vol (20d)780.58K

Avg $ vol (20d)649.35K

Market cap6.28M

RS 3m (vs SPY)-73.66%

RS 6m (vs SPY)+199.77%

RS line new highNo

Trend template4/8

Technical rank39.6

1 week-5.80%

1 month-44.19%

3 months-66.51%

6 months+206.30%

1 year+17.90%

YTD+176.01%

P/E-0.27

P/B-0.20

P/S3.63

P/FCF-0.32

EPS-0.3100

Div yield—

ROE73.05%

ROA-258.47%

Debt/Eq-0.23

Current0.33

EV/EBITDA-0.60

Gross margin—

Net margin—

Rev growth40.04%

EPS growth13.39%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value12.45M

Revenue985.08K

Net income-6.66M

Gross profit—

Free cash flow-19.77M

IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

ExchangeNYSE

Shares out8.63M

Employees75

ListedWed, Apr 25, 2007

Free float98.87M

Float %72.9%

Short interest267.69K

Days to cover1.3d

Short volume68.4%

Squeeze score26 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction27 / 100

Pattern quality—

Tech rank39.6 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.55

Support0.9301

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VNRX

All disclosures →

No recent disclosed trades by Congress in VNRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VNRX

No recent insider (Form 4) filings in VNRX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in VNRX · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.